Fauci calls US coronavirus testing delays "totally unacceptable"

Elias Hubbard
August 6, 2020

The top U.S. infectious diseases Anthony Fauci says drugmakers will likely have tens of millions of doses of coronavirus vaccines in the early part of next year, with production ramping up to a billion doses by the end of 2021.

Drugmakers will likely have tens of millions of doses of coronavirus vaccines in the early part of next year, with production ramping up to a billion doses by the end of 2021, Anthony Fauci, the top USA infectious diseases official, has said in a Reuters interview. "We have a pretty comprehensive portfolio that's going to subsequently be going into clinical trials".

"As long as you have any member of society, any demographic group, who's not seriously trying to get to the end game of suppressing this, it will continue to smolder and smolder and smolder, and that will be the reason why, in a non-unified way, we've plateaued at an unacceptable level", Fauci said.

"I know when I say that if we follow these five or six principles, we can open up, we don't have to stay shut. there are some people that just don't believe me or don't pay attention to that".

He said he has not seen any pressure from the White House to announce a successful vaccine close to the November 3 election in the hopes of boosting President Donald Trump's re-election chances. "It will go away like things go away".

Fauci said that another pandemic is likely and recommended that there should be a more centralized and uniformed approach by the federal government to dealing with the spread of the virus.

The United States is committed to spending billions of dollars on vaccines being produced by companies including Johnson & Johnson, Moderna Inc, Pfizer Inc, Novavax Inc and Sanofi SA, employing a variety of technologies. "It's nearly related to authority and a mistrust in authority that spills over", Fauci said. "The proof of the pudding is the randomised placebo controlled trial".

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER